BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38680862)

  • 1. [Epidemiological characteristics of early-onset colorectal cancer: a prospective cohort study from a single center].
    Jin T; Zhu YS; Liu CC; Xu X; Lu W; Xiao Q; Ding KF; Zheng S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):457-463. PubMed ID: 38778685
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis.
    Baronas VA; Arif AA; Bhang E; Ladua GK; Brown CJ; Donnellan F; Gill S; Stuart HC; Loree JM
    Curr Oncol; 2024 Apr; 31(4):2133-2144. PubMed ID: 38668061
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early-onset colorectal cancer: A narrative review.
    Garrett C; Steffens D; Ackland S; Solomon M; Koh C
    Asia Pac J Clin Oncol; 2024 May; ():. PubMed ID: 38776256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress of diagnosis and treatment of early-onset colorectal cancer].
    Li YQ; Li XX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):441-446. PubMed ID: 38778682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multi-omics research progress in early-onset colorectal cancer].
    Chen SL; Xin JY; Du ML; Wang ML
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):447-451. PubMed ID: 38778683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of early-onset colorectal cancer.
    Marx O; Mankarious M; Yochum G
    World J Biol Chem; 2023 Mar; 14(2):13-27. PubMed ID: 37034132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and biology of early onset colorectal cancer.
    Venugopal A; Carethers JM
    EXCLI J; 2022; 21():162-182. PubMed ID: 35221839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes and splicing events in early-onset colorectal cancer.
    Marx OM; Mankarious MM; Koltun WA; Yochum GS
    Front Oncol; 2024; 14():1365762. PubMed ID: 38680862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of alanyl aminopeptidase is a robust biomarker of non-familial adenomatous polyposis and non-hereditary nonpolyposis colorectal cancer syndrome early-onset colorectal cancer.
    Ha YJ; Shin YJ; Tak KH; Park JL; Kim JH; Lee JL; Yoon YS; Kim CW; Kim SY; Kim JC
    Cancer Med; 2023 Apr; 12(8):10091-10104. PubMed ID: 36748835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.
    Gao XH; Li J; Liu LJ; Zheng NX; Zheng K; Mei Z; Bai CG; Zhang W
    Int J Surg; 2022 Aug; 104():106780. PubMed ID: 35850466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Transcriptome and Methylome Study Comparing Tissues of Early and Late Onset Colorectal Carcinoma.
    Kibriya MG; Raza M; Quinn A; Kamal M; Ahsan H; Jasmine F
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses.
    Zhang S; Xu R; Hu M; Choueiry F; Jin N; Li J; Mo X; Zhu J
    J Pharm Biomed Anal; 2024 Apr; 241():115978. PubMed ID: 38237540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic Variation and Risk Factor Association of Early Versus Late Onset Colorectal Cancer.
    Dong W; Kim U; Rose J; Hoehn RS; Kucmanic M; Eom K; Li S; Berger NA; Koroukian SM
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.
    Yang J; Zhao Y; Yuan R; Wang Y; Wang S; Chang Z; Zhao W
    Eur J Med Res; 2023 Nov; 28(1):533. PubMed ID: 37986009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling.
    Morel M; Long W
    Mol Oncol; 2024 Mar; 18(3):762-777. PubMed ID: 37983945
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.